Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004431 · ClinicalTrials.gov registry record · NA
Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00004431 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 30 participants.
The verdict
NCT00004431, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Evaluate the efficacy of L-baclofen in patients with refractory trigeminal neuralgia. II. Evaluate the safety and tolerance of L-baclofen in these patients.
Interventions
- DRUG L-baclofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 1998-06 |
| Est. Completion | 1999-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004431
The ClinicalTrials.gov registry entry for NCT00004431 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which L-baclofen is the first listed.
NCT00004431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004431 about?
NCT00004431 is a clinical study titled "Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia". OBJECTIVES: I. Evaluate the efficacy of L-baclofen in patients with refractory trigeminal neuralgia. II. Evaluate the safety and tolerance of L-baclofen in these patients.
What is the current status of trial NCT00004431?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 1998-06. Estimated completion is 1999-09.
What interventions are being tested in trial NCT00004431?
The interventions under investigation include: L-baclofen (DRUG).
Who is sponsoring clinical trial NCT00004431?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.